glp-1 and PDB-101: Molecule of the Month:

The data enables both you and your healthcare provider to customize your treatment strategy

Miplyffas approval was backed by data from a 12-month multicenter, randomized, double-blind, placebo-controlled trial that investigated the treatment in NPC patients 2 to 19 years of age

No product was independently tested

Do you feel you could use some guidance on how to lose weight or that you would benefit from a medical weight loss program

Poor nutrition and obesity disproportionately affect individuals with lower socioeconomic status in rural communities and in racial and ethnic minoritized populations [226], and disparities in poor nutrition and obesity prevalence are mirrored in disparities in access to quality health care [227]